For tumor metastasis, TANs facilitate epithelial–mesenchymal transition (EMT) via IL-17, TGF-β, and NE [73,74,75], decreasing cell adhesion and enhancing tumor cell motility. The gene discussed is TGFB1; the disease is neoplasm.